Insider Buying: Second Sight Medical Products Inc (EYES) Director Purchases 7,645 Shares of Stock

Share on StockTwits

Second Sight Medical Products Inc (NASDAQ:EYES) Director Gregg Williams acquired 7,645 shares of the company’s stock in a transaction that occurred on Monday, October 15th. The shares were acquired at an average price of $1.63 per share, with a total value of $12,461.35. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Gregg Williams also recently made the following trade(s):

  • On Thursday, October 18th, Gregg Williams acquired 2,467,767 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.62 per share, with a total value of $3,997,782.54.
  • On Thursday, October 11th, Gregg Williams acquired 11,709 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.60 per share, with a total value of $18,734.40.
  • On Tuesday, October 9th, Gregg Williams acquired 10,458 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.64 per share, with a total value of $17,151.12.
  • On Friday, October 5th, Gregg Williams acquired 15,875 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.72 per share, with a total value of $27,305.00.
  • On Wednesday, October 3rd, Gregg Williams acquired 24,075 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.79 per share, with a total value of $43,094.25.
  • On Friday, September 28th, Gregg Williams acquired 9,223 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.90 per share, with a total value of $17,523.70.
  • On Monday, October 1st, Gregg Williams acquired 25,098 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.88 per share, with a total value of $47,184.24.
  • On Wednesday, September 26th, Gregg Williams acquired 10,878 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.96 per share, with a total value of $21,320.88.
  • On Monday, September 24th, Gregg Williams acquired 15,520 shares of Second Sight Medical Products stock. The shares were acquired at an average price of $1.86 per share, with a total value of $28,867.20.
  • On Friday, September 21st, Gregg Williams bought 15,875 shares of Second Sight Medical Products stock. The stock was purchased at an average price of $1.80 per share, with a total value of $28,575.00.

Shares of EYES stock traded down $0.08 during mid-day trading on Friday, hitting $1.54. The stock had a trading volume of 684,094 shares, compared to its average volume of 175,057. Second Sight Medical Products Inc has a 12-month low of $1.13 and a 12-month high of $2.58. The stock has a market capitalization of $114.03 million, a price-to-earnings ratio of -2.61 and a beta of 2.91.

Second Sight Medical Products (NASDAQ:EYES) last issued its earnings results on Wednesday, November 7th. The medical device company reported ($0.12) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Second Sight Medical Products had a negative return on equity of 582.43% and a negative net margin of 408.41%. The business had revenue of $2.25 million during the quarter, compared to analysts’ expectations of $2.48 million. Analysts forecast that Second Sight Medical Products Inc will post -0.58 EPS for the current fiscal year.

Several brokerages have weighed in on EYES. Zacks Investment Research cut Second Sight Medical Products from a “hold” rating to a “sell” rating in a report on Monday, August 13th. HC Wainwright set a $5.00 target price on Second Sight Medical Products and gave the stock a “buy” rating in a report on Wednesday, August 8th. Finally, ValuEngine cut Second Sight Medical Products from a “buy” rating to a “hold” rating in a report on Thursday.

COPYRIGHT VIOLATION NOTICE: “Insider Buying: Second Sight Medical Products Inc (EYES) Director Purchases 7,645 Shares of Stock” was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://baseballnewssource.com/2018/11/10/gregg-williams-purchases-7645-shares-of-second-sight-medical-products-inc-eyes-stock/2847125.html.

Second Sight Medical Products Company Profile

Second Sight Medical Products, Inc develops, manufactures and markets prosthetic devices. Its product the Argus II System, treats outer retinal degenerations and employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.

Featured Story: What does EPS mean?

Insider Buying and Selling by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Receive News & Ratings for Second Sight Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Second Sight Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.